AzTrials
AzTrials

Orthodontic Appliance ComplicationNCT04871763

Assessment of Bacterial Loads of Essix Retainers in Patients Under Retention Therapy

A study testing Retainers' Cleansing with Geldis®, Retainers' Cleansing with tablets and Retainers' cleansing with water in people with Orthodontic Appliance Complication, run by University of Pavia at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to investigate the bacterial loads present on essix retainers in patients' contention therapy. Patients are randomly divided into three groups, depending on the product used for the cleansing of the retainers: Geldis, Polident tablets and water. Read more about this study

Who is it for?
Ages 18 to 50 yearsHealthy volunteers can take part
Conditions the study is for
Orthodontic Appliance Complication
What is being tested?
Retainers' Cleansing with Geldis®, Retainers' Cleansing with tablets and Retainers' cleansing with water
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
15 participants
Where
1 siteItaly
Study dates
12 May 2021to 18 Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Patients who completed orthodontic treatment and under Essix retainers phase.

Who cannot join

  • Patients under orthodontic treatment with fixed appliances or clear aligners.
  • Non-orthodontic patients.

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Unit of Dental Hygiene - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Paediatrics - University of Pavia

    Pavia, Lombardy, 27100

Other trials in Italy

About this study

Official title: A Protocol for the Assessment of the Bacterial Loads of Essix Retainers in Patients Under Retention Therapy: a Randomized Clinical Trial

The aim of this study is to investigate the bacterial loads present on essix retainers in patients' contention therapy. Patients are randomly divided into three groups, depending on the product used for the cleansing of the retainers: Geldis, Polident tablets and water. Microbiological samples were taken from the retainers at the baseline, after 1 and after 2 months, together with Bleeding Index, Plaque Index, BEWE Index and Schiff Air Sensitivity test.

Read the detailed description

The aim of this study is to investigate the bacterial loads present on essix retainers in patients' contention therapy. Patients who wear essix retainers for contention therapy are randomly divided into three groups, depending on the product used for the cleansing of the retainers: Geldis, Polident tablets and water. Periodontal evaluation and microbiological samples are conducted at the baseline, after 1 and after 2 months.

Bacterial loads are collected from essix retainers, whereas Bleeding Index, Plaque Index, BEWE Index and Schiff Air Sensitivity test are assessed from the patients' mouth.

Being tested
Retainers' Cleansing with Geldis®, Retainers' Cleansing with tablets, Retainers' cleansing with water
Keywords
oral microbiota, essix retainer, periodontal assessment

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Retainers' Cleansing with Geldis®Other

    Patients will clean their essix retainers with Geldis® using a toothbrush every night for 2 months.

  • Retainers' Cleansing with tabletsOther

    Patients will leave their essix retainers in a glass with water and Polident tablets every night for 2 months.

  • Retainers' cleansing with waterOther

    Patients will brush their essix retainers with a toothbrush under water every night for 2 months.

Study groups in NCT04871763
Study groupRoleWhat they receive
Geldis® gelExperimentalPatients will brush their essix retainers with a toothbrush and with Geldis® gel.
Receives: Other: Retainers' Cleansing with Geldis®
TabletsActive comparatorPatients will leave their essix retainers in a glass with water and Polident tablets.
Receives: Other: Retainers' Cleansing with tablets
WaterActive comparatorPatients will brush essix retainers with a toothbrush under running water.
Receives: Other: Retainers' cleansing with water

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in PCR% - Plaque Control Record (percentage)

    % assessment of the amount of plaque on dental surfaces; it is detected on 4 surfaces: distal, mesial, vestibular, lingual / palatal. The number of sites with plaque is divided by the total number of sites available in the mouth and multiplied by 100. Results indicate the index as a percentage.

    Measured: Study begin, 1 and 2 months

  2. Change in BOP - Bleeding on Probing (percentage)

    Site-specific assessment of the presence or absence of gum bleeding after the insertion of the periodontal probe for the detection of PPD, detected on 4 sites (mesial, distal, vestibular, palatal/lingual).

    Percentage of sites with bleeding on probing determines the BOP%.

    Measured: Study begin, 1 and 2 months

  3. Change in Schiff Air Index - Dental sensitivity test

    Scoring criteria:

    • 0: the subject did not respond to air blasting;
    • 1: the subject responded to air blasting;
    • 2: the subject responded to air blasting and requested discontinuation;
    • 3: the subject responded to air blasting, requested discontinuation and considered the stimulus to be painful.

    Measured: Study begin, 1 and 2 months

  4. Change of the BEWE Index - Basic Erosive Wear Examination (Barlet et al., 2008)

    Scoring criteria:

    0: no erosive tooth wear;

    1. initial loss of surface texture;
    2. distinct defect, hard tissue loss < 50% of the surface area;
    3. hard tissue loss ≥ 50% of the surface area.

    Measured: Study begin, 1 and 2 months

  5. Change in microbiological loads of clear aligners

    Microbiological assessment of the following loads:

    • Porphyromonas gingivalis
    • Tannarella forsythensis
    • Treponema denticola
    • Peptostreptococcus micros
    • Total bacterial load

    Measured: Study begin, 1 and 2 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 May 2021
  2. Study start12 May 2021
  3. Primary completion15 Dec 2021
  4. Study completion18 Dec 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
15 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04871763
Sponsor's protocol ID
2021-ESSIX
Status last verified
Dec 2021
First submitted
27 Apr 2021
Last updated
21 Dec 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Data will be available upon motivated request to Principal Investigator

Questions about this trial

What is this clinical trial studying?

A study testing Retainers' Cleansing with Geldis®, Retainers' Cleansing with tablets and Retainers' cleansing with water in people with Orthodontic Appliance Complication, run by University of Pavia at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Dec 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in PCR% - Plaque Control Record (percentage) (time frame: Study begin, 1 and 2 months). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Dec 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in